0001136261-20-000138.txt : 20200612
0001136261-20-000138.hdr.sgml : 20200612
20200612161517
ACCESSION NUMBER: 0001136261-20-000138
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20200611
FILED AS OF DATE: 20200612
DATE AS OF CHANGE: 20200612
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Mehra Raj
CENTRAL INDEX KEY: 0001757892
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 000-22245
FILM NUMBER: 20960349
MAIL ADDRESS:
STREET 1: C/O SEELOS THERAPEUTICS, INC.
STREET 2: 300 PARK AVENUE, 12TH FLOOR
CITY: NEW YORK
STATE: NY
ZIP: 10022
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: SEELOS THERAPEUTICS, INC.
CENTRAL INDEX KEY: 0001017491
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 870449967
STATE OF INCORPORATION: NV
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 300 PARK AVENUE
CITY: NEW YORK
STATE: NY
ZIP: 10017
BUSINESS PHONE: (646) 998-6475
MAIL ADDRESS:
STREET 1: 300 PARK AVENUE
CITY: NEW YORK
STATE: NY
ZIP: 10017
FORMER COMPANY:
FORMER CONFORMED NAME: APRICUS BIOSCIENCES, INC.
DATE OF NAME CHANGE: 20100914
FORMER COMPANY:
FORMER CONFORMED NAME: NEXMED INC
DATE OF NAME CHANGE: 19970311
4
1
primary_doc.xml
PRIMARY DOCUMENT
X0306
4
2020-06-11
0
0001017491
SEELOS THERAPEUTICS, INC.
SEEL
0001757892
Mehra Raj
C/O SEELOS THERAPEUTICS, INC.
300 PARK AVENUE, 12TH FLOOR
NEW YORK
NY
10022
1
1
1
0
See Remarks
Stock Option (right to buy)
1.08
2020-06-11
4
A
0
2282262
0
A
2030-06-11
Common Stock
2282262
2282262
D
1/4th of the shares subject to the option shall vest on June 11, 2021, and 1/48th of the shares subject to the option shall vest monthly thereafter, subject to the Reporting Person's continued service to the Issuer through each such vesting date.
President, Chief Executive Officer, Chairman of the Board of Directors and Interim Chief Financial Officer
/s/ Raj Mehra, Ph.D.
2020-06-12